Healthcare Business Today: Who Owns the Problem of Patient Compliance? Insights on Elemental Diet Accessibility
In a recent Healthcare Business Today article, mBIOTA Labs CEO Nicola Wodlinger explores the challenges surrounding patient compliance, particularly in relation to elemental diets for gastrointestinal health. Historically, elemental diets have been effective for managing conditions like Crohn's disease and Small Intestinal Bacterial Overgrowth (SIBO). However, due to their unpleasant taste, many patients discontinue use, limiting their therapeutic potential. A study noted that up to 41% of patients withdrew from elemental diet trials due to poor palatability.
Highlighting mBIOTA Labs' work, Wodlinger emphasizes that a patient-centered approach—one that includes direct feedback from patients and healthcare providers—was essential to developing mBIOTA Elemental™, a palatable option that recently achieved a 100% compliance rate in clinical trials. The article calls for collaboration across healthcare sectors to make treatments more accessible and tolerable, positioning patient experience as a shared responsibility between practitioners, product developers, and the broader medical community.
